智通财经网·2026-03-29 08:40Core Viewpoint - Xinhua Pharmaceutical (000756.SZ) reported a revenue of 8.755 billion yuan for the year 2025, reflecting a year-on-year growth of 3.41%, while the net profit attributable to shareholders decreased by 38.32% to 290 million yuan [1] Financial Performance - The company achieved a revenue of 8.755 billion yuan, which is a 3.41% increase compared to the previous year [1] - The net profit attributable to shareholders was 290 million yuan, showing a decline of 38.32% year-on-year [1] - The net profit after deducting non-recurring items was 268 million yuan, down 40.10% from the previous year [1] - Basic earnings per share stood at 0.42 yuan [1] Dividend Distribution - The company plans to distribute a year-end dividend of 0.15 yuan per share (before tax) to all shareholders [1]